C. Kinnon

发表

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

D. Bentley, D. Vetrie, R. Levinsky, 1993, Nature.

Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2Rγ chain gene by single-strand conformation polymorphism analysis

R. Levinsky, P. Clark, R. Hendriks, 1995, Human Genetics.

Enhancer‐deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD

J. Roes, A. Thrasher, C. Kinnon, 2004, The journal of gene medicine.

Gene therapy of inherited immunodeficiencies

A. Thrasher, C. Kinnon, G. Santilli, 2008, Current hematology reports.

Gene therapy for primary immunodeficiency

A. Thrasher, A. Thrasher, C. Kinnon, 2011, Current opinion in pediatrics.

Quality of repopulation in nonobese diabetic severe combined immunodeficient mice engrafted with expanded cord blood CD34+ cells.

G. Sirchia, A. Thrasher, J. Goldman, 1999, Blood.

Detailed characterization of the human aorta‐gonad‐mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer

A. Thrasher, C. Kinnon, P. Thorogood, 1999 .

Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.

Kathryn L. Parsley, J. Bueren, M. Grez, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Wiskott-Aldrich syndrome protein, WASP.

C. Kinnon, P. Brickell, E. O'Sullivan, 1999, The international journal of biochemistry & cell biology.

Non‐viral, integrin‐mediated gene transfer into fibroblasts from patients with lysosomal storage diseases

C. Kinnon, B. Winchester, Elaine Joanna Estruch, 2001, The journal of gene medicine.

The identification of Bruton's tyrosine kinase and Wiskott-Aldrich syndrome protein associated proteins and signalling pathways.

R. Lovering, I. Gout, S. Banin, 1997, Biochemical Society transactions.

Phosphorylation of WASp is a key regulator of activity and stability in vivo

S. Snapper, Gareth E. Jones, A. Worth, 2009, Proceedings of the National Academy of Sciences of the United States of America.

Intrinsic dendritic cell abnormalities in Wiskott‐Aldrich syndrome

Gareth E. Jones, A. Thrasher, C. Kinnon, 1998, European journal of immunology.

Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency.

C. Kinnon, K. Gilmour, E. Davies, 2001, Blood.

Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.

Kathryn L. Parsley, P. Veys, A. Thrasher, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.

A. Minty, P. Ferrara, D. Caput, 1995, Blood.

Gene therapy of inherited immunodeficiencies.

A. Thrasher, C. Kinnon, G. Santilli, 2003, Expert opinion on biological therapy.

Pulsed-field gel electrophoresis and radiation hybrid mapping analyses enable the ordering of eleven DNA loci in Xq22.

S. Malcolm, C. Kinnon, R. Levinsky, 1993, Genomics.

Lentiviral vectors for gene therapy of Type I Gaucher Disease

Christine Kinnon, Kl Aitchison, Ahad A. Rahim, 2011 .

Somatic gene therapy for genetic disease.

R. Levinsky, C. Kinnon, 1990, Archives of disease in childhood.

Gene therapy for cancer.

R. Levinsky, C. Kinnon, 1990, European journal of cancer.

An integrin-targeted non-viral vector for pulmonary gene therapy

R. Jenkins, S. Hart, R. McAnulty, 2000, Gene Therapy.

Apoptotic Cells Protein Is Required for Efficient Phagocytosis of Cutting Edge: The Wiskott-Aldrich Syndrome

A. Ridley, Y. Leverrier, A. Thrasher, 2001 .

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain

J. D. Di Santo, A. Thrasher, J. Goldman, 1998 .

Animal Models of Human Primary Immunodeficiency Diseases

C. Kinnon, M. Blundell, 2012 .

The Mechanism of Intracellular Transport and Surface Expression of MHC Antigens

C. Kinnon, M. Owen, 1985 .

A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector.

R. Levinsky, A. Thrasher, M. Grez, 2000, Human gene therapy.

Differential regulation of T cell receptor gamma genes in immature thymocyte populations

E. Rothenberg, C. Kinnon, K. McGuire, 1987, European journal of immunology.

SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.

A. Thrasher, C. Kinnon, K. Gilmour, 2004, Blood.

Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis.

R. Lovering, R. Levinsky, C. Kinnon, 1994, Human molecular genetics.

Adeno-associated virus gene transfer to mouse retina.

D. Hunt, S. Bhattacharya, R. Levinsky, 1998, Human gene therapy.

Gene transfer into the mouse retina mediated by an adeno-associated viral vector.

D. Hunt, R. Levinsky, S. Bhattacharya, 1996, Human molecular genetics.

Functional reconstitution of the NADPH-oxidase by adeno-associated virus gene transfer.

R. Levinsky, A. Segal, J. Lebkowski, 1995, Blood.

Immunodeficiency: Long-term persistence of a polyclonal t cell repertoire after gene therapy for X-linked severe combined immunodeficiency

Kathryn L. Parsley, S. Cooray, A. Thrasher, 2011 .

Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency

Kathryn L. Parsley, S. Cooray, A. Thrasher, 2011, Science Translational Medicine.

Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12

S. Hart, A. Thrasher, C. Kinnon, 2003, British Journal of Cancer.

B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia.

R. Hendriks, J. Borst, C. Kinnon, 1994, The Journal of biological chemistry.

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain.

J. D. Di Santo, A. Thrasher, J. Goldman, 1998, British journal of haematology.

BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

M. Vihinen, H. Ochs, J. Ollila, 1996, Nucleic acids research.

Biosynthesis of HLA-A and -B Antigens

M. Owen, C. Kinnon, A. Kissonerghis, 1982 .

The impact of retroviral suicide gene transduction procedures on T cells

S. Verfuerth, A. Thrasher, C. Kinnon, 2003, British journal of haematology.

Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression.

C. Porter, R. Levinsky, C. Kinnon, 1996, Blood.

Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency.

David A. Williams, A. Schambach, N. Sebire, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Intrinsic defects of B cell function in X‐linked severe combined immunodeficiency

P. Veys, A. Thrasher, A. Thrasher, 2000, European journal of immunology.

Generation of Trispecific Cytotoxic T Cells Recognizing Cytomegalovirus, Adenovirus, and Epstein-Barr Virus: An Approach for Adoptive Immunotherapy of Multiple Pathogens

P. Veys, P. Amrolia, C. Kinnon, 2007, Journal of immunotherapy.

p 22-phox-Deficient Chronic Granulomatous Disease : Reconstitution by Retrovirus-Mediated Expression and Identification of a Biosynthetic Intermediate of gp 91-phox

Arthur, K. Collins, C. Kinnon, 2002 .

p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.

C. Porter, R. Levinsky, A. Verhoeven, 1994, Blood.

Clathrin-coated vesicles purified from a human B lymphocyte cell line contain newly synthesized glycoproteins.

C. Kinnon, M. Owen, 1983, The Journal of biological chemistry.

X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.

C. Porter, R. Levinsky, C. Kinnon, 1993, Blood.

The synthesis and expression of HLA-A and -B antigens in Xenopus laevis oocytes.

C. Kinnon, M. Owen, 1986, Molecular immunology.

BTKbase: a database of XLA-causing mutations. International Study Group.

M. Vihinen, G. Litman, M. Cooper, 1995, Immunology today.

Mutation analysis in CD40 ligand deficiency leading to X‐linked hypogammaglobulinemia with hyper IgM syndrome

C. Kinnon, A. Jones, P. Rutland, 1996, Human mutation.

Characterization of the murine heat‐stable antigen: An hematolymphoid differentiation antigen defined by the J11d, M1/69 and B2A2 antibodies

C. Kinnon, I. N. Crispe, L. Alterman, 1990, European journal of immunology.

The murine heat‐stable antigen: a differentiation antigen expressed in both the hematolymplioid and neural cell lineages

G. Rougon, C. Kinnon, Xia Guo, 1991, European journal of immunology.

Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays.

C. Porter, R. Levinsky, C. Kinnon, 1992, Journal of immunological methods.

The lymphocyte membrane.

C. Kinnon, M. Collins, Christine Kinnon, 1984, Immunology today (Amsterdam. Regular ed.).

Bone morphogenetic protein 4 modulates c-Kit expression and differentiation potential in murine embryonic aorta-gonad-mesonephros haematopoiesis in vitro

A. Thrasher, C. Kinnon, C. Marshall, 2007, British journal of haematology.

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency

Rafael J. Yáñez-Muñoz, C. von Kalle, P. Gregory, 2018, Scientific Reports.

Improvement of migratory defects in a murine model of Wiskott-Aldrich syndrome gene therapy.

A. Thrasher, C. Kinnon, Y. Calle, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region.

A. Thrasher, C. Kinnon, C. Marshall, 2000, Blood.

Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectors

David A. Williams, M. F. Mata, G. Wagemaker, 2018, Experimental hematology.

CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome.

A. Villa, M. Vihinen, S. Giliani, 1996, Immunology today.

The protein defective in X‐linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross‐linked

R. Lovering, R. Levinsky, C. Kinnon, 1995, European journal of immunology.

T cell transduction and suicide with an enhanced mutant thymidine kinase

A. Thrasher, C. Kinnon, W. Qasim, 2002, Gene Therapy.

Capture and generation of adenovirus specific T cells for adoptive immunotherapy

H. Bobby Gaspar, C. Kinnon, W. Qasim, 2007, British journal of haematology.

Adeno-associated virus gene transfer to mouse retina. Human Gene Therapy

D. Hunt, S. Bhattacharya, R. Levinsky, 1998 .

Diagnosis of X‐linked lymphoproliferative disease by analysis of SLAM‐associated protein expression

K. Nichols, D. Goldblatt, A. Thrasher, 2000, European journal of immunology.

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12

A. Thrasher, S. Grosse, S. Hart, 2007, British Journal of Cancer.

Codon optimization of human factor VIII cDNAs leads to high-level expression.

A. Thrasher, T. VandenDriessche, M. Chuah, 2011, Blood.

Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

Christine Kinnon, Christof von Kalle, Dick de Ridder, 2007, The Journal of clinical investigation.

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.

Christine Kinnon, Christof von Kalle, Michael Hubank, 2008, The Journal of clinical investigation.

Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans

Christine Kinnon, Manfred Schmidt, R. Levinsky, 2006, Pediatrics.

Inherited immunodeficiencies.

C. Kinnon, 1995, Molecular and cell biology of human diseases series.

Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction

Kathryn L. Parsley, P. Veys, S. Cooray, 2011, Science Translational Medicine.

Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells

A. Schambach, A. Thrasher, M. Antoniou, 2007, Blood.

Gene therapy: has it delivered what it promised?

C. Kinnon, 2006, British journal of hospital medicine.

Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector.

R. Levinsky, C. Mailhos, R. Ali, 1998, Human gene therapy.

Effective gene therapy with nonintegrating lentiviral vectors

S. E. Barker, Rafael J. Yáñez-Muñoz, J. Heckenlively, 2006, Nature Medicine.

Properties of N-acetyl-beta-D-hexosaminidase from isolated normal and I-cell lysosomes.

C. Kinnon, A. Miller, E. Harms, 1981, The Journal of biological chemistry.

Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy

D. Hunt, S. Bhattacharya, S. Fauser, 2000, Nature Genetics.

Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein.

Samantha J. Hardy, A. Thrasher, J. Strid, 2005, Blood.

Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.

C. Porter, C. Kinnon, D. Roos, 1996, The Biochemical journal.

Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia.

Christine Kinnon, Austen Worth, A. Worth, 2006, Blood.

Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot.

R. Lovering, R. Levinsky, C. Kinnon, 1995, Human molecular genetics.

High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter

Kathryn L. Parsley, M. Grez, A. Thrasher, 2002 .

High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Kathryn L. Parsley, M. Grez, A. Thrasher, 2002, Human gene therapy.

Trisomy X in a female member of a family with X linked severe combined immunodeficiency: implications for carrier diagnosis.

R. Levinsky, P. Clark, M. de Alwis, 1994, Journal of medical genetics.

Lentiviral vectors for T-cell suicide gene therapy: preservation of T-cell effector function after cytokine-mediated transduction.

A. Thrasher, C. Kinnon, W. Qasim, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways.

R C Lovering, I Gout, C Kinnon, 1996, Journal of immunology.

The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase

R. Lovering, R. Levinsky, C. Kinnon, 1995, The Journal of experimental medicine.

X-linked agammaglobulinemia--gene cloning and future prospects.

R. Lovering, R. Levinsky, C. Kinnon, 1993, Immunology today.

The Wiskott–Aldrich syndrome

A. Thrasher, A. Thrasher, C. Kinnon, 2000, Clinical and experimental immunology.

B-cell-negative severe combined immunodeficiency associated with a common γ chain mutation

P. Clark, C. Kinnon, S. Genet, 1997, Human Genetics.

Prenatal diagnosis and carrier detection of inherited immunodeficiency disorders

R. Levinsky, C. Kinnon, A. Pelham, 1990 .

Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation.

C. Rodeck, E. Jauniaux, A. Thrasher, 2000, American journal of obstetrics and gynecology.

Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT.

R. Levinsky, S. Malcolm, A. Finn, 1992, Genomics.

Identification of deletions in thebtk gene allows unambiguous assessment of carrier status in families with X-linked agammaglobulinaemia

D. Bentley, D. Vetrie, R. Lovering, 1994, Human Genetics.

Physical mapping in the region of the Bruton's tyrosine kinase and α-galactosidase A gene loci in proximal Xq22

R. Lovering, R. Levinsky, C. Kinnon, 1994, Human Genetics.

Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients.

C. Kinnon, H. Gaspar, A. Jones, 1998, Clinical immunology and immunopathology.

Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cells.

R. Lovering, R. Levinsky, S. Malcolm, 1993, Journal of immunological methods.

The molecular basis of X-linked immunodeficiency disease

R. Levinsky, C. Kinnon, 1992, Journal of Inherited Metabolic Disease.

RFLP and deletion analysis for X-linked chronic granulomatous disease using the cDNA probe: potential for improved prenatal diagnosis and carrier determination.

R. Levinsky, S. Malcolm, C. Kinnon, 1990, Blood.

c-kit Activating Mutations and Mast Cell Proliferation in Human Leukemia

M. Peitsch, A. Fischer, W. Friedrich, 2017 .

Protein assays for diagnosis of Wiskott–Aldrich syndrome and X‐linked thrombocytopenia

A. Finn, A. Thrasher, C. Kinnon, 2001, British journal of haematology.

Is Wiskott--Aldrich syndrome a cell trafficking disorder?

G. E. Jones, A. Thrasher, G. Jones, 1998, Immunology today.

Rapid protein‐based assays for the diagnosis of T–B+ severe combined immunodeficiency

C. Kinnon, K. Gilmour, E. Davies, 2001, British journal of haematology.

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis.

C Kinnon, A. Thrasher, C. Kinnon, 2000, Blood.

X-Linked Agammaglobulinemia

C. Kinnon, H. Gaspar, Surjit Singh, 2016 .

Kinase mutant Btk results in atypical X‐linked agammaglobulinaemia phenotype

I. Caragol, C. Kinnon, H. Gaspar, 2000, Clinical and experimental immunology.

The technique of pulsed field gel electrophoresis and its impact on molecular immunology.

C. Kinnon, M. O'Reilly, 1990, Journal of immunological methods.

Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia

Christine Kinnon, David G. Spiller, Adrian J. Thrasher, 2007, The Journal of experimental medicine.

Expression of Bruton's tyrosine kinase protein within the B cell lineage

R. Callard, R. Lovering, R. Levinsky, 1994, European journal of immunology.

Activation of T cell antigen receptor alpha- and beta-chain genes in the thymus: implications for the lineages of developing cortical thymocytes.

E. Rothenberg, C. Kinnon, R. Diamond, 1986, Journal of immunology.

Gene transfer to primary chronic granulomatous disease monocytes

R. Levinsky, A. Segal, A. Thrasher, 1995, The Lancet.

Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer.

A. Thrasher, C. Kinnon, P. Thorogood, 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

Cutting Edge: The Wiskott-Aldrich Syndrome Protein Is Required for Efficient Phagocytosis of Apoptotic Cells1

Yann Leverrier, Christine Kinnon, Adrian J. Thrasher, 2001, The Journal of Immunology.

The X‐linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene

F. Grosveld, R. Hendriks, G. Dingjan, 1997, European journal of immunology.

The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto‐phosphorylated in vitro

C. Kinnon, P. Costello, Giles O. C. Cory, 1999, European journal of immunology.

Expression of the X-linked agammaglobulinemia gene, btk in B-cell acute lymphoblastic leukemia.

R. Lovering, R. Levinsky, C. Kinnon, 1994, Leukemia.

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

R. Levinsky, S. Inglis, R. Ali, 1999, Human gene therapy.

Deletion mapping of the DXS986, DXS995, and DXS1002 loci defines their order within Xq21.

P. Clark, L. Villard, C. Kinnon, 1994, Journal of medical genetics.

Pillars Article: The Gene Involved in X-linked Agammaglobulinaemia Is a Member of the Src Family of Protein-Tyrosine Kinases. Nature. 1993. 361: 226–233

Christine Kinnon, Frances Flinter, David R. Bentley, 2012 .

Analysis of Bruton's tyrosine kinase protein expression and activity in patients with X-linked agammaglobulinemia (XLA):the use of protein analysis as a diagnostic indicator of XLA

R. Levinsky, C. Kinnon, H. Gaspar, 1998 .

BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

Mauno Vihinen, Christine Kinnon, Igor Vorechovsky, 1996, Nucleic Acids Res..

Mapping of the X linked form of hyper IgM syndrome (HIGM1)

R. Levinsky, A. Read, S. Malcolm, 1993, Journal of medical genetics.

Isolation and mapping of discrete DXS101 loci in Xq22 near the X-linked agammaglobulinaemia gene locus

R. Lovering, R. Levinsky, S. Malcolm, 1993, Human Genetics.

Physical mapping identifies DXS265 as a useful genetic marker for carrier detection and prenatal diagnosis of X-linked agammaglobulinemia

R. Levinsky, S. Malcolm, C. Kinnon, 1993, Human Genetics.

Identification of CpG islands around the DXS178 locus in the region of the X-linked agammaglobulinaemia gene locus in Xq22

R. Levinsky, S. Malcolm, C. Kinnon, 1992, Human Genetics.

HCN4 subunit expression in fast-spiking interneurons of the rat spinal cord and hippocampus

J. A. Quayle, R. Callister, C. Kinnon, 2013, Neuroscience.

Physical mapping in the region of human Xq12-21.1 using pulsed field gel electrophoresis

R. Levinsky, S. Malcolm, C. Kinnon, 1993, Human Genetics.

X linked agammaglobulinaemia with a 'leaky' phenotype.

R. Thompson, C. Kinnon, A. Jones, 1996, Archives of disease in childhood.

Intrinsic dendritic cell abnormalities in Wiskott‐Aldrich syndrome

A. Thrasher, C. Kinnon, D. Katz, 1998, European journal of immunology.

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

Kathryn L. Parsley, R. Levinsky, R. Ali, 2004, The Lancet.

Genetic mapping of two loci, DXS454 and DXS458, with respect to the X-linked agammaglobulinemia gene locus

R. Lovering, R. Levinsky, C. Kinnon, 2004, Human Genetics.

Bone morphogenetic protein‐4 (BMP4) up regulates key haematopoietic genes in differentiating embryonic stem cells treated with BMP4 short hairpin RNA

A. Thrasher, C. Kinnon, A. Abeyewickreme, 2011, British Journal of Haematology.

Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome

Dunn, A. Thrasher, C. Kinnon, 1998, British journal of haematology.

Update on treatment of human SCID-X1 by somatic gene therapy using a pseudotyped gammaretroviral vector

Kathryn L. Parsley, A. Thrasher, S. Howe, 2004 .

Phosphorylation of WASp is a key regulator of activity and stability in vivo

S. Snapper, A. Worth, S. Burns, 2009, Proceedings of the National Academy of Sciences.

Detection of gp 91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b 558 biosynthesis

C. Porter, C. Kinnon, D. Roos, 1996 .

The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto‐phosphorylated in vitro

C. Kinnon, P. Costello, Giles O. C. Cory, 1999, European journal of immunology.

Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia

D. Spiller, M. White, A. Thrasher, 2007, The Journal of experimental medicine.

Targeted Lentiviral Gene Therapy to Rescue the X-CGD Phenotype

Christine Kinnon, Juan A. Bueren, Aj Thrasher, 2010 .

Enhancement of integrin‐mediated transfection of haematopoietic cells with a synthetic vector system

C. Mailhos, S. Hart, A. Uduehi, 2003, Biotechnology and applied biochemistry.

Erratum: Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction (Science Translational Medicine (2013) 5 (168er1))

P. Veys, S. Cooray, A. Thrasher, 2013 .

Cyclooxygenase-2 overexpression, using an integrin-targeted gene delivery system (the LID vector), inhibits fibroblast proliferation in vitro and leads to increased prostaglandin E(2) in the lung.

G. Laurent, G. Jenkins, S. Hart, 2002, Chest.